b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30429236</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>07</Month>\n            <Day>29</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>03</Month>\n            <Day>09</Day>\n        </DateRevised>\n        <Article PubModel="Electronic-Print">\n            <Journal>\n                <ISSN IssnType="Electronic">1573-4935</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>39</Volume>\n                    <Issue>1</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>01</Month>\n                        <Day>31</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Bioscience reports</Title>\n                <ISOAbbreviation>Biosci. Rep.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p/CCND2 axis.</ArticleTitle>\n            <ELocationID EIdType="pii" ValidYN="Y">BSR20181440</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1042/BSR20181440</ELocationID>\n            <Abstract>\n                <AbstractText>The aim of the present study was to investigate the potential role of GAS8 antisense RNA 1 (GAS8-AS1) in papillary thyroid carcinoma (PTC). PcDNA3.1-GAS8-AS1 and si-GAS8-AS1, miR-135b-5p mimic and si-CCND2 were transfected into PTC cells. Cell proliferation was evaluated by Cell Counting Kit-8 (CCK-8). QRT-PCR was used to determine expressions of GAS8-AS1, miR-135b-5p, and CCND2, and Western blot were detected protein level of CCND2. The miRNA target gene prediction site TargetScan was used to predict potential targets of GAS8-AS1 and miR-135b-5p. Cell cycle progression was analyzed by flow cytometry. We found that GAS8-AS1 was down-regulated in PTC cell lines and inhibited proliferation and cycle of PTC cell. GAS8-AS1 directly targets miR-135b-5p, and GAS8-AS1 could regulate a downstream target of miR-135b-5p, Cyclin G2 (CCNG2), in an miR-135b-5p-mediated manner. In addition, we also proved that overexpressed GAS8-AS1 inhibited tumor formation <i>in vivo</i> GAS8-AS1 suppresses PTC cell growth through the miR-135b-5p/CCND2 axis.</AbstractText>\n                <CopyrightInformation>\xc2\xa9 2019 The Author(s).</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Chen</LastName>\n                    <ForeName>NingHeng</ForeName>\n                    <Initials>N</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>General Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Yin</LastName>\n                    <ForeName>DeTao</ForeName>\n                    <Initials>D</Initials>\n                    <Identifier Source="ORCID">0000-0003-1088-2142</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>General Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China detaoyin@sohu.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lun</LastName>\n                    <ForeName>Bing</ForeName>\n                    <Initials>B</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Obstetrics Department, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Guo</LastName>\n                    <ForeName>XueLi</ForeName>\n                    <Initials>X</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>General Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>01</Month>\n                <Day>11</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>Biosci Rep</MedlineTA>\n            <NlmUniqueID>8102797</NlmUniqueID>\n            <ISSNLinking>0144-8463</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C080336">CCND2 protein, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D056742">Cyclin D2</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D003598">Cytoskeletal Proteins</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C115742">GAS8 protein, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C544965">MIRN135 microRNA, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D009363">Neoplasm Proteins</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D062085">RNA, Long Noncoding</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002453" MajorTopicYN="N">Cell Cycle</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D056742" MajorTopicYN="N">Cyclin D2</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003598" MajorTopicYN="N">Cytoskeletal Proteins</DescriptorName>\n                <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015972" MajorTopicYN="Y">Gene Expression Regulation, Neoplastic</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008819" MajorTopicYN="N">Mice, Nude</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009363" MajorTopicYN="N">Neoplasm Proteins</DescriptorName>\n                <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D062085" MajorTopicYN="N">RNA, Long Noncoding</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000077273" MajorTopicYN="N">Thyroid Cancer, Papillary</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013964" MajorTopicYN="N">Thyroid Neoplasms</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D047368" MajorTopicYN="N">Tumor Burden</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D023041" MajorTopicYN="N">Xenograft Model Antitumor Assays</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">CCND2</Keyword>\n            <Keyword MajorTopicYN="Y">GAS8-AS1</Keyword>\n            <Keyword MajorTopicYN="Y">PTC</Keyword>\n            <Keyword MajorTopicYN="Y">miR-135b-5p</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>08</Month>\n                <Day>21</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>16</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>02</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>16</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>7</Month>\n                <Day>30</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>16</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30429236</ArticleId>\n            <ArticleId IdType="pii">BSR20181440</ArticleId>\n            <ArticleId IdType="doi">10.1042/BSR20181440</ArticleId>\n            <ArticleId IdType="pmc">PMC6328895</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>J Thyroid Res. 2011;2011:631593</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22496986</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biochim Biophys Acta. 2016 Jan;1859(1):169-76</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26149773</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Gene. 2018 Apr 15;650:60-67</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29408583</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Endocrinol Metab. 2016 Aug;101(8):3036-44</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27186860</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biochem Biophys Res Commun. 2018 Feb 5;496(2):628-632</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29366479</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2016 Nov 22;7(47):77978-77986</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27793001</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Biochem Cell Biol. 2018 May;98:1-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29474928</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Tumour Biol. 2014 Mar;35(3):2631-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24248541</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>CA Cancer J Clin. 2013 Nov-Dec;63(6):374-94</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23797834</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Ther Nucleic Acids. 2016 Oct 11;5(10):e374</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27727247</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Hum Mol Genet. 2016 May 1;25(9):1875-84</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26941397</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Death Dis. 2018 Mar 7;9(3):380</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29515109</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biochem Biophys Res Commun. 2016 Feb 26;471(1):82-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26845350</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Anticancer Res. 2003 May-Jun;23(3B):2335-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12894512</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Cancer Res. 2015 Feb 15;5(3):907-27</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26045977</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncol Lett. 2018 Jan;15(1):1007-1013</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29399161</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2016 Mar 15;7(11):12731-47</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26871295</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2017 Sep 23;8(65):108665-108675</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29312559</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nature. 2014 Jan 16;505(7483):344-52</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24429633</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Cancer Res. 2018 Jan 01;8(1):192-206</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29416932</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Cancer Epidemiol. 2013;2013:965212</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23737785</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Oncol. 2018 Feb;52(2):589-598</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29345297</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2017 Dec 16;9(3):3519-3530</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29423063</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncol Lett. 2016 Jul;12(1):544-552</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27347178</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Ther Nucleic Acids. 2016 Nov 15;5(11):e385</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27845772</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biomed Pharmacother. 2017 Dec;96:1341-1348</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29196101</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Cancer. 2011 Nov 24;11(12):849-64</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22113163</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Adv Exp Med Biol. 2013;774:1-20</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23377965</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Ther Nucleic Acids. 2016 Mar 15;5:e296</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26978580</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Ther Nucleic Acids. 2016 Nov 15;5(11):e387</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27845771</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2017 Jul 10;8(37):62195-62207</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28977937</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncol Lett. 2015 Nov;10(5):2986-2990</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26722276</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biochem Biophys Res Commun. 2018 Feb 26;497(1):181-186</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29427661</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Annu Rev Biochem. 2012;81:145-66</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22663078</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell. 2011 Aug 5;146(3):353-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21802130</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biochem Biophys Res Commun. 2016 Sep 16;478(2):811-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27501756</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Endocrinol. 2017;2017:2645904</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28781594</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'